Carbazole

Carbazole

SCHEMBL143086

c1ccc2c(c1)[nH]c1ccccc12.c1ccc2c(c1)[nH]c1ncccc12

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
GPR3 P46089 1/20 0.58
HSD17B10 Q99714 1/20 0.58
PARP1 P09874 3/20 0.58
AURKA O14965 2/20 0.58
GABRA1 P14867 4/20 0.57
GABRG2 P18507 4/20 0.57
GABRB3 P28472 4/20 0.57
GABRA5 P31644 4/20 0.57
GABRA3 P34903 4/20 0.57
GABRA2 P47869 4/20 0.57
GABRP O00591 2/20 0.57
GABRD O14764 2/20 0.57
GABRB1 P18505 2/20 0.57
GABRB2 P47870 2/20 0.57
GABRA4 P48169 2/20 0.57
GABRE P78334 2/20 0.57
GABRA6 Q16445 2/20 0.57
GABRG1 Q8N1C3 2/20 0.57
GABRG3 Q99928 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbazole SCHEMBL28956846 1.00 ALDH1A1 (0.58) ALDH1A1GPR3HSD17B10PARP1AURKA
SCHEMBL29559082 0.98 PARP1 (0.60) ALDH1A1GPR3HSD17B10PARP1AURKA
SCHEMBL29410201 0.98 PARP1 (0.60) ALDH1A1GPR3HSD17B10PARP1AURKA
SCHEMBL9145 0.98 PARP1 (0.60) ALDH1A1GPR3HSD17B10PARP1AURKA
SCHEMBL28982242 0.96 PARP1 (0.58) ALDH1A1GPR3HSD17B10PARP1AURKA
Hydrochloric Acid SCHEMBL2770160 0.96 PARP1 (0.58) ALDH1A1GPR3HSD17B10PARP1AURKA
Formaldehyde SCHEMBL28560487 0.92 PARP1 (0.59) ALDH1A1GPR3HSD17B10PARP1AURKA
SCHEMBL27174122 0.91 PARP1 (0.56) ALDH1A1GPR3HSD17B10PARP1AURKA
Norharmane SCHEMBL6646064 0.89 CHUK (0.77) ALDH1A1PARP1AURKAGABRA1GABRG2
SCHEMBL18597137 0.88 MAPT (0.53) ALDH1A1GPR3HSD17B10PARP1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112028912-B Novel boron-containing organic electroluminescent material and application thereof 北京鼎材科技有限公司 2024-07-12 CN disclosed
CN-114933591-B Pyridine derivative and application thereof 北京鼎材科技有限公司 2024-06-04 CN disclosed
CN-110407810-B Organic electroluminescent material and application thereof 北京鼎材科技有限公司 2023-11-24 CN disclosed
CN-112614952-B Organic light-emitting device and display device 昆山国显光电有限公司 2022-09-16 CN disclosed
CN-114933591-A Pyridine derivatives and use thereof 北京鼎材科技有限公司 2022-08-23 CN disclosed
CN-110452239-B Nitrogen-containing heterocyclic compound, application thereof and organic electroluminescent device 北京鼎材科技有限公司 2022-03-29 CN disclosed
CN-112614952-A Organic electroluminescent device and display device 昆山国显光电有限公司 2021-04-06 CN disclosed
CN-112028912-A Novel boron-containing organic electroluminescent material and application thereof 北京鼎材科技有限公司 2020-12-04 CN disclosed
CN-110452239-A Nitrogen-containing heterocycle compound and its application and organic electroluminescence device BEIJING ETERNAL MAT TECH CO LTD 2019-11-15 CN disclosed
CN-110407810-A Organic electroluminescent material and application thereof BEIJING ETERNAL MAT TECH CO LTD 2019-11-05 CN disclosed
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
EP-2370407-B1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-06-18 EP disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
EP-2370407-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-10-05 EP disclosed
WO-2010080474-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed
JP-2004318049-A PHOTOSENSITIVE COMPOSITION AND NOVEL COMPOUND USING THE SAME FUJI PHOTO FILM CO LTD 2004-11-11 JP disclosed
JP-2004319439-A DYE-SENSITIZED SOLAR CELL AND ITS MANUFACTURING METHOD SHARP CORP 2004-11-11 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 ALDH1A1 1464/4885GPR3 1326/4885HSD17B10 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.